|
| Entrez Id: |
2 |
| Gene Symbol: |
A2M |
A2M
|
0.300 |
Biomarker
|
disease |
CTD_human |
Alpha-2 macroglobulin is genetically associated with Alzheimer disease.
|
9697696 |
1998 |
|
| Entrez Id: |
2 |
| Gene Symbol: |
A2M |
A2M
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease.
|
9811940 |
1998 |
|
| Entrez Id: |
2 |
| Gene Symbol: |
A2M |
A2M
|
0.300 |
Biomarker
|
disease |
CTD_human |
Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms.
|
15023809 |
2004 |
|
| Entrez Id: |
10347 |
| Gene Symbol: |
ABCA7 |
ABCA7
|
0.300 |
Biomarker
|
disease |
CTD_human |
Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease.
|
25807283 |
2015 |
|
| Entrez Id: |
10347 |
| Gene Symbol: |
ABCA7 |
ABCA7
|
0.300 |
Biomarker
|
disease |
CTD_human |
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.
|
21460840 |
2011 |
|
| Entrez Id: |
51225 |
| Gene Symbol: |
ABI3 |
ABI3
|
0.300 |
Biomarker
|
disease |
CTD_human |
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.
|
28714976 |
2017 |
|
| Entrez Id: |
1636 |
| Gene Symbol: |
ACE |
ACE
|
0.300 |
Biomarker
|
disease |
CTD_human |
Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease.
|
9916793 |
1999 |
|
| Entrez Id: |
1636 |
| Gene Symbol: |
ACE |
ACE
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.
|
17192785 |
2007 |
|
| Entrez Id: |
1636 |
| Gene Symbol: |
ACE |
ACE
|
0.300 |
Biomarker
|
disease |
CTD_human |
Alzheimer disease risk and genetic variation in ACE: a meta-analysis.
|
14872014 |
2004 |
|
| Entrez Id: |
1636 |
| Gene Symbol: |
ACE |
ACE
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.
|
30820047 |
2019 |
|
| Entrez Id: |
1636 |
| Gene Symbol: |
ACE |
ACE
|
0.300 |
Biomarker
|
disease |
CTD_human |
Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population.
|
10643899 |
1999 |
|
| Entrez Id: |
43 |
| Gene Symbol: |
ACHE |
ACHE
|
0.300 |
Biomarker
|
disease |
CTD_human |
Characterisation of acetylcholinesterase release from neuronal cells.
|
23047022 |
2013 |
|
| Entrez Id: |
43 |
| Gene Symbol: |
ACHE |
ACHE
|
0.300 |
Biomarker
|
disease |
CTD_human |
Lithium treatment induces proteasomal degradation of over-expressed acetylcholinesterase (AChE-S) and inhibit GSK3β.
|
22944069 |
2013 |
|
| Entrez Id: |
102 |
| Gene Symbol: |
ADAM10 |
ADAM10
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.
|
30820047 |
2019 |
|
| Entrez Id: |
9510 |
| Gene Symbol: |
ADAMTS1 |
ADAMTS1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.
|
30820047 |
2019 |
|
| Entrez Id: |
267 |
| Gene Symbol: |
AMFR |
AMFR
|
0.300 |
Biomarker
|
disease |
CTD_human |
Autocrine motility factor receptor is involved in the process of learning and memory in the central nervous system.
|
22313999 |
2012 |
|
| Entrez Id: |
341 |
| Gene Symbol: |
APOC1 |
APOC1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Hidden heterogeneity in Alzheimer's disease: Insights from genetic association studies and other analyses.
|
29107063 |
2018 |
|
| Entrez Id: |
341 |
| Gene Symbol: |
APOC1 |
APOC1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genome-Wide Association and Mechanistic Studies Indicate That Immune Response Contributes to Alzheimer's Disease Development.
|
30319691 |
2018 |
|
| Entrez Id: |
348 |
| Gene Symbol: |
APOE |
APOE
|
0.300 |
Biomarker
|
disease |
CTD_human |
Association Analysis of Polymorphisms in TOMM40, CR1, PVRL2, SORL1, PICALM, and 14q32.13 Regions in Colombian Alzheimer Disease Patients.
|
27023435 |
2017 |
|
| Entrez Id: |
348 |
| Gene Symbol: |
APOE |
APOE
|
0.300 |
Biomarker
|
disease |
CTD_human |
Hidden heterogeneity in Alzheimer's disease: Insights from genetic association studies and other analyses.
|
29107063 |
2018 |
|
| Entrez Id: |
348 |
| Gene Symbol: |
APOE |
APOE
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.
|
19734902 |
2009 |
|
| Entrez Id: |
348 |
| Gene Symbol: |
APOE |
APOE
|
0.300 |
Biomarker
|
disease |
CTD_human |
Testosterone modifies the effect of APOE genotype on hippocampal volume in middle-aged men.
|
20819998 |
2010 |
|
| Entrez Id: |
348 |
| Gene Symbol: |
APOE |
APOE
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genome-Wide Association and Mechanistic Studies Indicate That Immune Response Contributes to Alzheimer's Disease Development.
|
30319691 |
2018 |
|
| Entrez Id: |
348 |
| Gene Symbol: |
APOE |
APOE
|
0.300 |
Biomarker
|
disease |
CTD_human |
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.
|
24162737 |
2013 |
|
| Entrez Id: |
348 |
| Gene Symbol: |
APOE |
APOE
|
0.300 |
Biomarker
|
disease |
CTD_human |
Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.
|
30320580 |
2018 |